# US 2008/0313773 A1 · Production of artificial micrornas using synthetic microrna precursors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0313773 A1
- Document ID: US20080313773A1
- Status: Published application
- Kind: A1
- Application number: 12/117,095
- Filed: 2008-05-08
- Published: 2008-12-18
- Earliest claimed: 2007-05-14
- Assignees: The Rockefeller University
- Inventors: Nam-Hai CHUA; Qi-Wen NIU
- Web page: https://patentgrep.com/patent/US20080313773A1

## CPC

- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 2310/141: MicroRNAs, miRNAs
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention provides methods and compositions useful in target sequence suppression, target sequence validation and target sequence down regulation. The invention provides polynucleotide constructs useful for producing artificial microRNA (amiRNA) using synthetic amiRNA precursors.

## Claims

### Claim 1

A nucleic acid construct comprising a promoter operatively linked to a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary sequence are replaced by an amiRNA sequence and its complementary sequence, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA and wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor.

### Claim 2 (depends on 1)

The nucleic acid construct of claim 1, wherein the promoter is a host cell promoter.

### Claim 3 (depends on 1)

The nucleic acid construct of claim 1, wherein a site-specific recombination site is present between the promoter and the polynucleotide.

### Claim 4 (depends on 3)

The nucleic acid construct of claim 3, wherein the promoter is a host cell promoter.

### Claim 5 (depends on 1)

The nucleic acid construct of claim 1, wherein the miRNA precursor is a plant miRNA precursor.

### Claim 6 (depends on 1)

The nucleic acid construct of claim 1, wherein the amiRNA sequence is fully complementary to the target sequence.

### Claim 7 (depends on 1)

The nucleic acid construct of claim 1, wherein the amiRNA sequence is fully complementary to the target sequence except for GU base pairing.

### Claim 8 (depends on 1)

The nucleic acid construct of claim 1, wherein the target sequence is a RNA of a plant pathogen.

### Claim 9 (depends on 8)

The nucleic acid construct of claim 8, wherein the plant pathogen is a plant virus or plant viroid.

### Claim 10 (depends on 9)

The nucleic acid construct of claim 9, wherein the target sequence is selected from the group consisting of a sequence of a critical region of a virus, a conserved sequence of a family of viruses and a conserved sequence among members of different viral families.

### Claim 11 (depends on 1)

The nucleic acid construct of claim 1, wherein the target sequence is a contiguous sequence in a non-coding region of RNA.

### Claim 12 (depends on 1)

The nucleic acid construct of claim 1, wherein the target sequence is a contiguous sequence in a coding region of RNA.

### Claim 13 (depends on 1)

The nucleic acid construct of claim 1, wherein the target sequence is a contiguous sequence which overlaps a coding and a non-coding region of RNA.

### Claim 14 (depends on 1)

The nucleic acid construct of claim 1, wherein the target sequence comprises a splice site of RNA.

### Claim 15 (depends on 1)

A cell comprising the nucleic acid construct of claim 1.

### Claim 16 (depends on 15)

The cell of claim 15, wherein the cell is a plant cell.

### Claim 17 (depends on 1)

A transgenic plant comprising the nucleic acid of claim 1.

### Claim 18 (depends on 1)

A transgenic seed comprising the nucleic acid of claim 1.

### Claim 19

A cell comprising a host cell promoter operatively linked to a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary (miRNA* strand) sequence are replaced by an amiRNA sequence and its fully complementary sequence, respectively, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA and wherein the host cell promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor.

### Claim 20 (depends on 19)

The cell of claim 19, wherein a site-specific recombination site is present between the host cell promoter and the polynucleotide.

### Claim 21 (depends on 19)

The cell of claim 19, wherein the cell is a plant cell.

### Claim 22

A transgenic plant comprising a host cell promoter operatively linked to a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary (miRNA* strand) sequence are replaced by an amiRNA sequence and its fully complementary sequence, respectively, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA and wherein the host cell promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor.

### Claim 23 (depends on 22)

The transgenic plant of claim 22, wherein a site-specific recombination site is present between the host cell promoter and the polynucleotide.

### Claim 24

A transgenic seed comprising a host cell promoter operatively linked to a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary (miRNA* strand) sequence are replaced by an amiRNA sequence and its fully complementary sequence, respectively, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA and wherein the host cell promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor.

### Claim 25 (depends on 24)

The transgenic seed of claim 24, wherein a site-specific recombination site is present between the host cell promoter and the polynucleotide.

### Claim 26

A method for down regulating a target sequence in a cell comprising:
(a) introducing into a cell a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary (miRNA* strand) sequence are replaced by an amiRNA sequence and its fully complementary sequence, respectively, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA, wherein the polynucleotide is operably linked to a promoter, and wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor and
(b) growing the cell of (a) under conditions wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor, the amiRNA is produced and the RNA containing the target sequence is cleaved.

### Claim 27 (depends on 26)

The method of claim 26, wherein the promoter is a host cell promoter.

### Claim 28 (depends on 26)

The method of claim 26, wherein a site-specific recombination site is present between the promoter and the polynucleotide.

### Claim 29 (depends on 28)

The method of claim 28, wherein the promoter is a host cell promoter.

### Claim 30 (depends on 26)

The method of claim 26, wherein the cell is a plant cell.

### Claim 31 (depends on 26)

The method of claim 26, wherein the RNA containing the target sequence is cleaved within the target sequence.

### Claim 32 (depends on 31)

The method of claim 31, wherein the modified miRNA is a plant miRNA modified to be fully complementary to the target sequence.

### Claim 33 (depends on 31)

The method of claim 31, wherein the modified miRNA is a plant miRNA modified to be fully complementary to the target sequence except for the use of GU base pairing.

### Claim 34 (depends on 26)

The method of claim 26, wherein the target sequence is a contiguous sequence in an RNA of a plant pathogen.

### Claim 35 (depends on 34)

The method of claim 34, wherein the plant pathogen comprising the target sequence is a plant virus or plant viroid.

### Claim 36 (depends on 35)

The method of claim 35, wherein the target sequence is selected from the group consisting of a sequence of a critical region of a virus, a conserved sequence of a family of viruses and a conserved sequence among members of different viral families.

### Claim 37 (depends on 26)

The method of claim 26, wherein the target sequence is a contiguous sequence in a coding region of RNA.

### Claim 38 (depends on 26)

The method of claim 26, wherein the target sequence is a contiguous sequence in a non-coding region of RNA.

### Claim 39 (depends on 26)

The method of claim 26, wherein the target sequence is a contiguous sequence which overlaps a coding region and a non-coding region of RNA.

### Claim 40 (depends on 26)

The method of claim 26, wherein the target sequence comprises a splice site of RNA.

### Claim 41 (depends on 26)

The method of claim 26, wherein the nucleic acid construct is inserted into an intron of a gene or transgene of the cell.

### Claim 42

A method for producing artificial miRNA (amiRNA) in a cell comprising:
(a) introducing into a cell a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary (miRNA* strand) sequence are replaced by an amiRNA sequence and its fully complementary sequence, respectively, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA, wherein the polynucleotide is operably linked to a promoter, and wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor and
(b) growing the cell of (a) under conditions wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor and the amiRNA is produced.

### Claim 43 (depends on 42)

The method of claim 42, wherein the promoter is a host cell promoter.

### Claim 44 (depends on 42)

The method of claim 42, wherein a site-specific recombination site is present between the promoter and the polynucleotide.

### Claim 45 (depends on 44)

The method of claim 44, wherein the promoter is a host cell promoter.

### Claim 46 (depends on 42)

The method of claim 42, wherein the cell is a plant cell.

### Claim 47

A method to assay for production of an artificial miRNA comprising the steps of:
(a) identifying a precursor miRNA containing a miRNA sequence and a complementary miRNA sequence (a miRNA* strand sequence),
(b) introducing into a cell a nucleic acid construct comprising a promoter operably linked to a polynucleotide encoding an artificial miRNA (amiRNA) precursor wherein the amiRNA precursor comprises the following:
(1) an artificial miRNA sequence replacing the endogenous miRNA sequence;
(2) a fully complementary sequence of the artificial miRNA replacing the endogenous miRNA* strand sequence; and
wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor;
(c) growing the cell of (b) under conditions wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor; and
(d) assaying for production of the artificial miRNA.

### Claim 48 (depends on 47)

The method of claim 47, wherein the amiRNA precursor of step (b) further comprises:
(3) replacement of one or more potential GU base pairs in the predicted secondary structure of the amiRNA precursor with one or more CG or AT base pairs.

### Claim 49 (depends on 47)

The method of claim 47, wherein the amiRNA precursor of step (b) further comprises:
(3) replacement of one or more potential GC base pairs in the predicted secondary structure of the amiRNA precursor with one or more AT base pairs.

### Claim 50 (depends on 47)

The method of claim 47, wherein the amiRNA precursor of step (b) further comprises:
(3) replacement of one or more potential AT base pairs in the predicted secondary structure of the amiRNA precursor with one or more CG base pairs.

### Claim 51

A method for down regulating an RNA containing a target sequence in a plant comprising:
(a) introducing into a plant cell a polynucleotide which encodes an artificial miRNA (amiRNA) precursor capable of forming a double-stranded RNA or a hairpin, wherein the amiRNA precursor comprises a modified miRNA precursor in which the miRNA sequence and its complementary (miRNA* strand) sequence are replaced by an amiRNA sequence and its fully complementary sequence, respectively, wherein the amiRNA sequence is (i) fully complementary to a target sequence, (ii) fully complementary to the target sequence except for GU base pairing or (iii) fully complementary to the target sequence in the first ten nucleotides counting from the 5′ end of the amiRNA, wherein the polynucleotide is operably linked to a promoter, and wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor,
(b) regenerating a plant from the plant cell of (a) wherein the plant comprises in its genome the nucleic acid construct,
(c) growing the plant of (b) under conditions wherein the promoter initiates and mediates transcription of the antisense strand of the amiRNA precursor, the amiRNA is produced and the RNA containing the target sequence is cleaved.

### Claim 52 (depends on 51)

The method of claim 51, wherein the promoter is a host cell promoter.

### Claim 53

Use of a synthetic pre-miRNA to generate one or more mature miRNAs in transformants to down regulate one or more target genes.

### Claim 54 (depends on 53)

The use of claim 53, wherein the synthetic pre-miRNA is selected from the group consisting of a modified native pre-miRNA, an antisense native pre-miRNA, an antisense native modified pre-miRNA and an artificial designed pre-miRNA.

### Claim 55 (depends on 53)

The use of claim 53, wherein the mature miRNA is a native mature miRNA or an amiRNA.

### Claim 56 (depends on 53)

The use of claim 53, wherein the transformant is a transformed plant cell, a transformed non-human animal cell, a transformed human cell in vitro, a transformed animal stem cell or a transformed human stem cell.

### Claim 57 (depends on 53)

The use of claim 53, wherein the transformant is a transformed plant or a transformed non-human animal.
